Gene expression correlation of immune checkpoint molecules Siglec-15 and PD-L1 varies widely by cancer indication

被引：0
|
作者：
Watkins, Krystal
Diao, Liyang
Crochiere, Marsha
Pinkas, Jan
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-1373
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1373
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Prognostic value of PD-L1 and Siglec-15 expression in patients with nasopharyngeal carcinoma
    Ju Zhao
    Hanshan Yang
    Hui Hu
    Chao Liu
    Min Wei
    Yumei Zhao
    Yudan Chen
    Yongxia Cui
    Ping Chen
    Kang Xiong
    Yun Lu
    Hongru Yang
    Linglin Yang
    Scientific Reports, 12
  • [2] Prognostic value of PD-L1 and Siglec-15 expression in patients with nasopharyngeal carcinoma
    Zhao, Ju
    Yang, Hanshan
    Hu, Hui
    Liu, Chao
    Wei, Min
    Zhao, Yumei
    Chen, Yudan
    Cui, Yongxia
    Chen, Ping
    Xiong, Kang
    Lu, Yun
    Yang, Hongru
    Yang, Linglin
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [3] Expression and function of Siglec-15 in RLPS and its correlation with PD-L1: Bioinformatics Analysis and Clinicopathological Evidence
    Cui, Lixuan
    Tian, Xiuyun
    Yan, Liang
    Guan, Xiaoya
    Dong, Bin
    Zhao, Min
    Lv, Ang
    Liu, Daoning
    Wu, Jianhui
    Hao, Chunyi
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2022, 19 (13): : 1977 - 1988
  • [4] Expression patterns of PD-L1 and other immune checkpoint molecules in gastric cancer.
    Nakamura, Kenichi
    Hatakeyama, Keiichi
    Toriumi, Tetsuro
    Koseki, Yusuke
    Waki, Yuhei
    Fujiya, Keiichi
    Kamiya, Satoshi
    Makuuchi, Rie
    Tanizawa, Yutaka
    Bando, Etsuro
    Kawamura, Taiichi
    Yamaguchi, Ken
    Terashima, Masanori
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [5] Siglec-15 on macrophages suppress the immune microenvironment in patients with PD-L1 negative non-metastasis lung adenocarcinoma
    Huang, Ziqi
    Guo, Yan
    Li, Baihui
    Shen, Meng
    Yi, Yeran
    Li, Li
    Zhao, Xiaohe
    Yang, Lili
    CANCER GENE THERAPY, 2024, 31 (03) : 427 - 438
  • [6] Siglec-15 on macrophages suppress the immune microenvironment in patients with PD-L1 negative non-metastasis lung adenocarcinoma
    Ziqi Huang
    Yan Guo
    Baihui Li
    Meng Shen
    Yeran Yi
    Li Li
    Xiaohe Zhao
    Lili Yang
    Cancer Gene Therapy, 2024, 31 : 427 - 438
  • [7] Co-expression patterns of immune checkpoint molecules in relation to PD-L1 expression.
    Pal, Sumanta K.
    Vanderwalde, Ari M.
    Szeto, Christopher
    Benz, Stephen Charles
    Sanborn, John Zachary
    Vaske, Charles Joseph
    Reddy, Sandeep K.
    Hamid, Omid
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [8] Immune checkpoint inhibitors of PD-L1 as cancer therapeutics
    Akinleye, Akintunde
    Rasool, Zoaib
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (01)
  • [9] Immune checkpoint inhibitors of PD-L1 as cancer therapeutics
    Akintunde Akinleye
    Zoaib Rasool
    Journal of Hematology & Oncology, 12
  • [10] PD-L1 expression in penile cancer: a new frontier for immune checkpoint inhibitors?
    Al-Ahmadie, H.
    ANNALS OF ONCOLOGY, 2016, 27 (09) : 1658 - 1659
12345